Benzinga | Nov 9, 2021 04:56PM EST

Avalo Therapeutics Q3 EPS $(0.17) Down From $(0.16) YoY, Sales $1.35M Up From $1.11M YoY

Avalo Therapeutics (NASDAQ:AVTX) reported quarterly losses of $(0.17) per share. This is a 6.25 percent decrease over losses of $(0.16) per share from the same period last year. The company reported $1.35 million in sales this quarter. This is a 21.51 percent increase over sales of $1.11 million the same period last year.